Browsing Tag
Illumina
10 posts
GRAIL (Nasdaq: GRAL) files FDA application for Galleri test, aiming to redefine how cancer is detected in asymptomatic patients
GRAIL files FDA approval for Galleri, its blood-based test for early cancer detection. Find out what it means for diagnostics, payers, and public health.
Prinses Máxima Center adopts Volta Labs’ Callisto platform to transform clinical genomics workflows
Prinses Máxima Center adopts Volta Labs’ Callisto platform to automate sequencing workflows, boosting pediatric cancer diagnostics with Illumina and ONT.
AI just got personal: Illumina and Tempus team up to make DNA testing part of every doctor’s visit
Find out how Illumina and Tempus are transforming healthcare with AI-driven genomic tools to advance precision medicine across cancer, cardiology, and more.
Ginkgo Bioworks enhances NGS workflows by integrating Volta Labs’ Callisto Sample Prep System
Ginkgo Bioworks, a leader in synthetic biology and biosecurity, has integrated Volta Labs’ Callisto Sample Prep System into…
Illumina teams up with Broad Clinical Labs to drive drug discovery collaboration
Illumina, Inc., a global leader in genomic sequencing technology, has announced a strategic collaboration with Broad Clinical Labs…
The future of biomedical research? Illumina’s spatial transcriptomics could unlock unprecedented discoveries
Illumina, Inc. has introduced an innovative spatial transcriptomics technology, designed to significantly enhance the mapping of complex tissues…
Illumina’s stunning victory against EU regulators changes the game for mergers
In a landmark decision that could redefine the boundaries of European merger control, the Court of Justice of…
Illumina secures FDA approval for comprehensive cancer test and two companion diagnostics
Illumina, Inc. (NASDAQ: ILMN), a global leader in the field of DNA sequencing and array-based technologies, has secured…
European Commission approves Illumina’s divestment plan for GRAIL
The European Commission, exercising its authority under the EU Merger Regulation (EUMR), has granted approval to Illumina’s proposed…
Illumina to take full ownership of cancer screening company GRAIL in $8bn deal
Illumina acquisition of GRAIL : US sequencing company Illumina has agreed to fully acquire California-based cancer screening company…